Arvinas logo

Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells

D T Saenz, et al.

February 2, 2017
Nature
Skip to content